Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT06985407

Grape Extract and Exercise Effects on Blood Pressure

Acute and Chronic Effects of Grape Extract on Cardiovascular Response Following Exercise

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
University of Castilla-La Mancha · Academic / Other
Sex
All
Age
25 Years – 70 Years
Healthy volunteers
Not accepted

Summary

Exercise and grape extract intake (i.e., polyphenol-rich product) can independently improve blood pressure and endothelial function in prehypertensive individuals. Nevertheless, their combined effects remain unexplored. Furthermore, since the biological pathways targeted by both interventions are similar, they could overlap and be amplified by one another, promoting additive or synergistic effects. Animal model studies have reported that a grape seed extract intake prevents exercise-induced oxidative stress, which could improve vascular dysfunction. Furthermore, as previously reported, a single dose of grape seed extract reduces blood pressure, peripheral vasoconstriction, and heart stress, enhancing O2 delivery during exercise in prehypertensive males. These effects may be partly due to endothelium-dependent vasodilation enhancement. Therefore, it is necessary to understand the potential impact of exercise and grape extract on blood pressure and vascular function in prehypertensive individuals.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTGrape extract (VinteraTM Premium OPC)Each condition will last 7 days for assessing both acute and chronic effects, and there will be a wash-out period of 7 days.
DIETARY_SUPPLEMENTControl (placebo) groupEach condition will last 7 days for assessing both acute and chronic effects, and there will be a wash-out period of 7 days.

Timeline

Start date
2026-02-10
Primary completion
2026-04-01
Completion
2026-06-01
First posted
2025-05-22
Last updated
2026-03-30

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06985407. Inclusion in this directory is not an endorsement.